Takeda France
在场
是其中之一......
Takeda Pharmaceutical 是一家在股票代码 4502 (JP) 下上市的公司。
Takeda Pharmaceutical 在 20 个国家有直接业务。Takeda Pharmaceutical 拥有 21家子公司，其中包括 Takeda Americas、Takeda APAC 和 Takeda Australia。
他们在：
高管
查看带有其 4 名主要高管的组织结构图
Takeda France 搜索最多的简介
- Rita Cataldo, Managing Director
- Céline Petit, Human Resources Director
- Houda Tazi Lavergne, Business Unit Head Rare Diseases
高管在Takeda Pharmaceutical变化
- Olivier Bohuon, Director, 已经去世。我们深感遗憾 (新闻发布的2024五月10号).
创建提醒
跟踪 Takeda France 的高管变动
药店
Takeda Pharmaceutical 拥有 1,831 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- Stemtech and Seacret Direct have announced they will merge (公布2024十二月5号)..
- Recursion Pharma and Exscientia have merged (公布2024十一月27号)..
- Stemtech and Seacret Direct have announced they will merge (公布2024十一月22号)..
药店 行业的其他推荐联系人
消息
Takeda France 的最新新闻稿
- Takeda to Present Data at American Society of Hematology Annual Meeting
- U.S. FDA Approves Takeda’s Treatment for Ultra-Rare Blood Clotting Disorder
- Takeda Phase 2b TAK-279 data in psoriatic arthritis ACR Convergence
- New colorectal cancer treatment approved in the U.S.
- Takeda Announces FY2023 H1 Results; Updates Full-Year Forecasts While Remaining on Track Towards Management Guidance
- Notice of the Revised Forecast of Consolidated Financials for FY2023 (IFRS)
- Takeda to Hold 2nd Quarter of FY2023 Earnings Call on October 26
- Takeda Announces Amendment of Compensation Recoupment Policy
- Takeda Announces Approval of CUVITRU Subcutaneous Immunoglobulin in Japan
- FDA Approves Subcutaneous Administration of ENTYVIO®
- View more press releases Close
关于 Takeda France 的社交媒体
保持联系
通过电子邮件联系联系该企业高管，包括 Rita Cataldo 
